150 related articles for article (PubMed ID: 16804887)
1. Distinguishing Costello versus cardio-facio-cutaneous syndrome: BRAF mutations in patients with a Costello phenotype.
Rauen KA
Am J Med Genet A; 2006 Aug; 140(15):1681-3. PubMed ID: 16804887
[No Abstract] [Full Text] [Related]
2. Cardio-facio-cutaneous syndrome: phenotypic variability and differential diagnosis in 3 cases with de novo BRAF mutations.
Demir E; Mancano G; Pomponi MG; Ozcelik A; Gucuyener K; Neri G
Neuropediatrics; 2010 Jun; 41(3):127-31. PubMed ID: 20859831
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical characterization of cardio-facio-cutaneous (CFC) syndrome: overlapping clinical manifestations with Costello syndrome.
Narumi Y; Aoki Y; Niihori T; Neri G; Cavé H; Verloes A; Nava C; Kavamura MI; Okamoto N; Kurosawa K; Hennekam RC; Wilson LC; Gillessen-Kaesbach G; Wieczorek D; Lapunzina P; Ohashi H; Makita Y; Kondo I; Tsuchiya S; Ito E; Sameshima K; Kato K; Kure S; Matsubara Y
Am J Med Genet A; 2007 Apr; 143A(8):799-807. PubMed ID: 17366577
[TBL] [Abstract][Full Text] [Related]
4. Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome.
Gripp KW; Lin AE; Nicholson L; Allen W; Cramer A; Jones KL; Kutz W; Peck D; Rebolledo MA; Wheeler PG; Wilson W; Al-Rahawan MM; Stabley DL; Sol-Church K
Am J Med Genet A; 2007 Jul; 143A(13):1472-80. PubMed ID: 17551924
[TBL] [Abstract][Full Text] [Related]
5. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
[TBL] [Abstract][Full Text] [Related]
6. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.
Makita Y; Narumi Y; Yoshida M; Niihori T; Kure S; Fujieda K; Matsubara Y; Aoki Y
J Pediatr Hematol Oncol; 2007 May; 29(5):287-90. PubMed ID: 17483702
[TBL] [Abstract][Full Text] [Related]
7. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.
Schulz AL; Albrecht B; Arici C; van der Burgt I; Buske A; Gillessen-Kaesbach G; Heller R; Horn D; Hübner CA; Korenke GC; König R; Kress W; Krüger G; Meinecke P; Mücke J; Plecko B; Rossier E; Schinzel A; Schulze A; Seemanova E; Seidel H; Spranger S; Tuysuz B; Uhrig S; Wieczorek D; Kutsche K; Zenker M
Clin Genet; 2008 Jan; 73(1):62-70. PubMed ID: 18042262
[TBL] [Abstract][Full Text] [Related]
8. Prenatal findings in cardio-facio-cutaneous syndrome.
Templin L; Baumann C; Busa T; Heckenroth H; Pouvreau N; Toutain A; Cave H; Verloes A; Sigaudy S; Philip N
Am J Med Genet A; 2016 Feb; 170A(2):441-445. PubMed ID: 26494162
[TBL] [Abstract][Full Text] [Related]
9. Costello syndrome and related disorders.
Quezada E; Gripp KW
Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.
Rodriguez-Viciana P; Tetsu O; Tidyman WE; Estep AL; Conger BA; Cruz MS; McCormick F; Rauen KA
Science; 2006 Mar; 311(5765):1287-90. PubMed ID: 16439621
[TBL] [Abstract][Full Text] [Related]
11. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
12. No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.
Neri G; Allanson J; Kavamura MI
J Med Genet; 2008 Dec; 45(12):832. PubMed ID: 19047498
[No Abstract] [Full Text] [Related]
13. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
Niihori T; Aoki Y; Narumi Y; Neri G; Cavé H; Verloes A; Okamoto N; Hennekam RC; Gillessen-Kaesbach G; Wieczorek D; Kavamura MI; Kurosawa K; Ohashi H; Wilson L; Heron D; Bonneau D; Corona G; Kaname T; Naritomi K; Baumann C; Matsumoto N; Kato K; Kure S; Matsubara Y
Nat Genet; 2006 Mar; 38(3):294-6. PubMed ID: 16474404
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome.
Rodriguez-Viciana P; Rauen KA
Methods Enzymol; 2008; 438():277-89. PubMed ID: 18413255
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
[TBL] [Abstract][Full Text] [Related]
16. Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations.
Armour CM; Allanson JE
J Med Genet; 2008 Apr; 45(4):249-54. PubMed ID: 18039946
[TBL] [Abstract][Full Text] [Related]
17. Partial deletion of chromosome 12q is not usually associated with CFC syndrome.
Zollino M; Neri G
Am J Med Genet; 2000 Nov; 95(3):296. PubMed ID: 11102944
[No Abstract] [Full Text] [Related]
18. A Postzygotic SMO Mutation Caused the Original Case of Happle-Tinschert Syndrome.
Zenker M; Tinschert S; Wieland I; Schanze D; Happle R
Acta Derm Venereol; 2018 Apr; 98(5):534-535. PubMed ID: 29335739
[No Abstract] [Full Text] [Related]
19. Gene symbol: BRAF. Disease: Cardio-facio-cutaneous syndrome.
Cave H
Hum Genet; 2008 Feb; 123(1):108-9. PubMed ID: 18386342
[No Abstract] [Full Text] [Related]
20. Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders.
Nyström AM; Ekvall S; Berglund E; Björkqvist M; Braathen G; Duchen K; Enell H; Holmberg E; Holmlund U; Olsson-Engman M; Annerén G; Bondeson ML
J Med Genet; 2008 Aug; 45(8):500-6. PubMed ID: 18456719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
